NCT07350629

Brief Summary

The goal of this observational study is to learn whether noninvasive real-time arterial waveform monitoring can be used to assess cardiovascular diseases in adults. The main question it aims to answer is: Can photoacoustic imaging accurately capture arterial waveforms from patients' fingers? Can features extracted from the arterial waveforms reflect the type and severity of cardiovascular diseases? Participants will be asked to place their fingers into the imaging device, where their finger arterial pulse information will be noninvasively recorded.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 25, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

December 26, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
12 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 20, 2026

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

December 25, 2025

Last Update Submit

January 11, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the state of aortic regurgitation and aortic stenosis by photoacoustic tomography

    To determine the feasibility of using photoacoustic tomography to differentiate aortic regurgitation and aortic stenosis based on arterial waveform measurements.

    At enrollment (single time point)

Secondary Outcomes (3)

  • Rise time of photoaocustic arterial waveform

    At enrollment (single time point)

  • Decay time of photoaocustic arterial waveform

    At enrollment (single time point)

  • Dicrotic notch time of photoaocustic arterial waveform

    At enrollment (single time point)

Study Arms (3)

Healthy Subjects

Healthy adult volunteers with no known cardiovascular disease will undergo noninvasive arterial waveform acquisition using the photoacoustic imaging device. No intervention is applied; data collection provides baseline waveform features for comparison with AR and AS patients.

Aortic Regurgitation (AR) Patients

Participants diagnosed with aortic regurgitation (AR) will undergo noninvasive arterial waveform acquisition using a photoacoustic imaging device. No intervention is applied; data collection focuses on capturing finger arterial pulse waveforms to assess features associated with AR.

Aortic Stenosis (AS) Patients

Participants diagnosed with aortic stenosis (AS) will undergo noninvasive arterial waveform acquisition using the same photoacoustic imaging device. No intervention is applied; data collection focuses on capturing finger arterial pulse waveforms to assess features associated with AS.

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from adult patients attending the cardiology department at the First Affiliated Hospital of University of Science and Technology of China, including individuals diagnosed with aortic regurgitation (AR) or aortic stenosis (AS), as well as healthy adult volunteers without known cardiovascular disease. Recruitment will focus on adults aged 18-80 years who are able to comply with finger arterial waveform measurement procedures.

You may qualify if:

  • Age 18-80 years
  • Able to provide informed consent
  • For AR group: clinically diagnosed aortic regurgitation
  • For AS group: clinically diagnosed aortic stenosis
  • For healthy controls: no history of cardiovascular disease
  • Able to undergo finger arterial waveform measurement

You may not qualify if:

  • History of recent cardiac surgery or intervention (\<6 months)
  • Hand disorders affecting finger mobility (e.g., arthritis)
  • Pregnant or breastfeeding women
  • Participation in other studies affecting arterial waveform
  • Unable to understand or comply with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of University of Science and Technology of China

Hefei, Anhui, 230026, China

RECRUITING

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

December 25, 2025

First Posted

January 20, 2026

Study Start

December 26, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

January 20, 2026

Record last verified: 2025-12

Locations